206 related articles for article (PubMed ID: 23515539)
1. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
Dalpke AH; Hofko M; Zorn M; Zimmermann S
J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
[TBL] [Abstract][Full Text] [Related]
4. Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.
Shin BM; Mun SJ; Yoo SJ; Kuak EY
J Clin Microbiol; 2012 Nov; 50(11):3765-7. PubMed ID: 22952270
[TBL] [Abstract][Full Text] [Related]
5. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection.
Karre T; Sloan L; Patel R; Mandrekar J; Rosenblatt J
J Clin Microbiol; 2011 Feb; 49(2):725-7. PubMed ID: 21123537
[TBL] [Abstract][Full Text] [Related]
8. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 3 automated real-time PCR (Xpert C. difficile assay, BD MAX Cdiff, and IMDx C. difficile for Abbott m2000 assay) for detecting Clostridium difficile toxin gene compared to toxigenic culture in stool specimens.
Yoo J; Lee H; Park KG; Lee GD; Park YG; Park YJ
Diagn Microbiol Infect Dis; 2015 Sep; 83(1):7-10. PubMed ID: 26081240
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.
Hirvonen JJ; Mentula S; Kaukoranta SS
J Clin Microbiol; 2013 Sep; 51(9):2908-12. PubMed ID: 23804386
[TBL] [Abstract][Full Text] [Related]
12. The importance of matrix-assisted laser desorption ionization-time of flight mass spectrometry for correct identification of Clostridium difficile isolated from chromID C. difficile chromogenic agar.
Chen JHK; Cheng VCC; Wong OY; Wong SCY; So SYC; Yam WC; Yuen KY
J Microbiol Immunol Infect; 2017 Oct; 50(5):723-726. PubMed ID: 26860352
[TBL] [Abstract][Full Text] [Related]
13. Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.
Stellrecht KA; Espino AA; Maceira VP; Nattanmai SM; Butt SA; Wroblewski D; Hannett GE; Musser KA
J Clin Microbiol; 2014 May; 52(5):1423-8. PubMed ID: 24554744
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces.
Terhes G; Urbán E; Sóki J; Nacsa E; Nagy E
J Clin Microbiol; 2009 Nov; 47(11):3478-81. PubMed ID: 19794052
[TBL] [Abstract][Full Text] [Related]
15. Novel one-step method for detection and isolation of active-toxin-producing Clostridium difficile strains directly from stool samples.
Darkoh C; Dupont HL; Kaplan HB
J Clin Microbiol; 2011 Dec; 49(12):4219-24. PubMed ID: 21976761
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the Verigene Clostridium difficile, Simplexa C. difficile Universal Direct, BD MAX Cdiff, and Xpert C. difficile assays for the detection of toxigenic C. difficile.
Gilbreath JJ; Verma P; Abbott AN; Butler-Wu SM
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):13-8. PubMed ID: 25027069
[TBL] [Abstract][Full Text] [Related]
17. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches.
Tenover FC; Novak-Weekley S; Woods CW; Peterson LR; Davis T; Schreckenberger P; Fang FC; Dascal A; Gerding DN; Nomura JH; Goering RV; Akerlund T; Weissfeld AS; Baron EJ; Wong E; Marlowe EM; Whitmore J; Persing DH
J Clin Microbiol; 2010 Oct; 48(10):3719-24. PubMed ID: 20702676
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic performance and accuracy of 3 molecular assays for the detection of Clostridium difficile in stool samples, compared with the Xpert® C. difficile assay.
Azrad M; Tkhawkho L; Hamo Z; Peretz A
J Microbiol Methods; 2020 Jan; 168():105784. PubMed ID: 31758952
[TBL] [Abstract][Full Text] [Related]
19. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
[TBL] [Abstract][Full Text] [Related]
20. Performance Evaluation of the Luminex Aries C. difficile Assay in Comparison to Two Other Molecular Assays within a Multihospital Health Care Center.
Juretschko S; Manji R; Khare R; Das S; Dunbar S
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31413082
[No Abstract] [Full Text] [Related]
[Next] [New Search]
